{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:29:21Z","timestamp":1791419361091,"version":"4.3.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-117692RB-I00 funded by MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID2020-117692RB-I00 funded by MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-33151-y","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T08:54:02Z","timestamp":1766220842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Altered PTPN13\u2013\u03b2-catenin interaction by pathogenic mutations and involvement of this axis in B-cell receptor signalling"],"prefix":"10.1038","volume":"16","author":[{"given":"David A.","family":"Cabrera-Riofr\u00edo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Garc\u00eda-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"S\u00e1nchez-Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"S\u00e1nchez-Yag\u00fce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigal","family":"Dror","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n M.","family":"Buey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0827-7963","authenticated-orcid":false,"given":"\u00c1ngel","family":"Hern\u00e1ndez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"33151_CR1","first-page":"281","volume":"24","author":"M Soulsby","year":"2009","unstructured":"Soulsby, M. & Bennett, A. M. Physiological signaling specificity by protein tyrosine phosphatases. Physiol. (Bethesda). 24, 281\u2013289 (2009).","journal-title":"Physiol. (Bethesda)"},{"key":"33151_CR2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nrm2039","volume":"7","author":"NK Tonks","year":"2006","unstructured":"Tonks, N. K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell. Biol. 7, 833\u2013846 (2006).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"33151_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-3746-2_1","volume":"1447","author":"A Alonso","year":"2016","unstructured":"Alonso, A., Nunes-Xavier, C. E., Bay\u00f3n, Y. & Pulido, R. The extended family of protein tyrosine phosphatases. Methods Mol. Biol. 1447, 1\u201323 (2016).","journal-title":"Methods Mol. Biol."},{"key":"33151_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10555-008-9114-2","volume":"27","author":"OD Abaan","year":"2008","unstructured":"Abaan, O. D. & Toretsky, J. A. PTPL1: a large phosphatase with a split personality. Cancer Metastasis Rev. 27, 205\u2013214 (2008).","journal-title":"Cancer Metastasis Rev."},{"key":"33151_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom10121659","volume":"10","author":"S McHeik","year":"2020","unstructured":"McHeik, S., Aptecar, L., Coopman, P., D\u2019hondt, V. & Freiss, G. Dual role of the PTPN13 tyrosine phosphatase in cancer. Biomolecules 10, 1\u201321 (2020).","journal-title":"Biomolecules"},{"key":"33151_CR6","doi-asserted-by":"publisher","first-page":"12766","DOI":"10.1074\/jbc.M112.429696","volume":"288","author":"W Huang","year":"2013","unstructured":"Huang, W., Bei, L. & Eklund, E. A. Fas-associated phosphatase 1 (Fap1) influences Betacatenin activity in myeloid progenitor cells expressing the Bcr-abl oncogene. J. Biol. Chem. 288, 12766\u201312776 (2013).","journal-title":"J. Biol. Chem."},{"key":"33151_CR7","doi-asserted-by":"publisher","first-page":"16160","DOI":"10.1073\/pnas.1007725107","volume":"107","author":"HT Tran","year":"2010","unstructured":"Tran, H. T., Sekkali, B., Van Imschoot, G., Janssens, S. & Vleminckx, K. Wnt\/beta-catenin signaling is involved in the induction and maintenance of primitive hematopoiesis in the vertebrate embryo. Proc. Natl. Acad. Sci. U S A. 107, 16160\u201316165 (2010).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"33151_CR8","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1038\/emboj.2012.150","volume":"31","author":"T Valenta","year":"2012","unstructured":"Valenta, T., Hausmann, G. & Basler, K. The many faces and functions of beta-catenin. EMBO J. 31, 2714\u20132736 (2012).","journal-title":"EMBO J."},{"key":"33151_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","volume":"17","author":"BT MacDonald","year":"2009","unstructured":"MacDonald, B. T., Tamai, K. & He, X. Wnt\/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell. 17, 9\u201326 (2009).","journal-title":"Dev. Cell."},{"key":"33151_CR10","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1016\/j.bbamcr.2014.08.014","volume":"1843","author":"JL Sardina","year":"2014","unstructured":"Sardina, J. L. et al. PTPN13 regulates cellular signalling and \u03b2-catenin function during megakaryocytic differentiation. Biochim. Biophys. Acta. 1843, 2886\u20132899 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"33151_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.stemcr.2015.08.003","volume":"5","author":"G L\u00f3pez-Ruano","year":"2015","unstructured":"L\u00f3pez-Ruano, G. et al. PTPN13 and \u03b2-catenin regulate the quiescence of hematopoietic stem cells and their interaction with the bone marrow niche. Stem cell. Rep. 5, 516\u2013531 (2015).","journal-title":"Stem cell. Rep."},{"key":"33151_CR12","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.bbadis.2013.05.022","volume":"1832","author":"WJAJ Hendriks","year":"2013","unstructured":"Hendriks, W. J. A. J. & Pulido, R. Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities. Biochim. Biophys. Acta. 1832, 1673\u20131696 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"33151_CR13","doi-asserted-by":"publisher","first-page":"e2266","DOI":"10.1002\/mgg3.2266","volume":"11","author":"X Wu","year":"2023","unstructured":"Wu, X., Wu, J., Yuan, Y., Yang, L. & Yu, L. Noonan syndrome: RhGH treatment and PTPN11 mutation. Mol. Genet. Genomic Med. 11, e2266 (2023).","journal-title":"Mol. Genet. Genomic Med."},{"key":"33151_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ajhg.2010.08.008","volume":"87","author":"AC Au","year":"2010","unstructured":"Au, A. C. et al. Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans. Am. J. Hum. Genet. 87, 436\u2013444 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"33151_CR15","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/ejn.12484","volume":"39","author":"J Chen","year":"2014","unstructured":"Chen, J. et al. A reduction in Ptprq associated with specific features of the deafness phenotype of the miR-96 mutant mouse diminuendo. Eur. J. Neurosci. 39, 744\u2013756 (2014).","journal-title":"Eur. J. Neurosci."},{"key":"33151_CR16","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1038\/s41375-022-01610-4","volume":"36","author":"H Moshiri","year":"2022","unstructured":"Moshiri, H. et al. Germline PTPN13 mutations in patients with bone marrow failure and acute lymphoblastic leukemia. Leukemia 36, 2132\u20132135 (2022).","journal-title":"Leukemia"},{"key":"33151_CR17","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.chembiol.2013.04.021","volume":"20","author":"TS Gujral","year":"2013","unstructured":"Gujral, T. S., Karp, E. S., Chan, M., Chang, B. H. & MacBeath, G. Family-wide investigation of PDZ domain-mediated protein-protein interactions implicates \u03b2-catenin in maintaining the integrity of tight junctions. Chem. Biol. 20, 816\u2013827 (2013).","journal-title":"Chem. Biol."},{"key":"33151_CR18","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/pro.2107","volume":"21","author":"Y Shi","year":"2012","unstructured":"Shi, Y. et al. Abnormal SDS-PAGE migration of cytosolic proteins can identify domains and mechanisms that control surfactant binding. Protein Sci. 21, 1197 (2012).","journal-title":"Protein Sci."},{"key":"33151_CR19","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1038\/s41388-020-1183-x","volume":"39","author":"G Lazarian","year":"2020","unstructured":"Lazarian, G. et al. Stabilization of \u03b2-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma. Oncogene 39, 2934\u20132947 (2020).","journal-title":"Oncogene"},{"key":"33151_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0165-4608(86)90055-5","volume":"19","author":"I Jack","year":"1986","unstructured":"Jack, I. et al. RCH-ACV: A lymphoblastic leukemia cell line with chromosome translocation 1;19 and trisomy 8. Cancer Genet. Cytogenet. 19, 261\u2013269 (1986).","journal-title":"Cancer Genet. Cytogenet."},{"key":"33151_CR21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2007-09-111344","volume":"112","author":"M Muzio","year":"2008","unstructured":"Muzio, M. et al. Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood 112, 188\u2013195 (2008).","journal-title":"Blood"},{"key":"33151_CR22","first-page":"115","volume":"293","author":"LS Taams","year":"2005","unstructured":"Taams, L. S. & Akbar, A. N. Peripheral generation and function of CD4\u2009+\u2009CD25\u2009+\u2009regulatory T cells. Curr. Top. Microbiol. Immunol. 293, 115\u2013131 (2005).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"33151_CR23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1365-2567.2006.02331.x","volume":"117","author":"M Brisslert","year":"2006","unstructured":"Brisslert, M. et al. Phenotypic and functional characterization of human CD25\u2009+\u2009B cells. Immunology 117, 548\u2013557 (2006).","journal-title":"Immunology"},{"key":"33151_CR24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/ajcp\/aqw178","volume":"146","author":"P Chen","year":"2016","unstructured":"Chen, P. et al. CD25 expression in B lymphoblastic leukemia\/lymphoma predicts t(9;22)(q34;q11)\/Philadelphia chromosome translocation (Ph) and is associated with residual disease in Ph-negative patients. Am. J. Clin. Pathol. 146, 632\u2013638 (2016).","journal-title":"Am. J. Clin. Pathol."},{"key":"33151_CR25","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1182\/blood.V128.22.4088.4088","volume":"128","author":"JW Lee","year":"2016","unstructured":"Lee, J. W. et al. CD25 enables oncogenic BCR signaling and represents a therapeutic target in refractory B cell malignancies. Blood 128, 4088\u20134088 (2016).","journal-title":"Blood"},{"key":"33151_CR26","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1002\/jcp.30760","volume":"237","author":"F Zeng","year":"2022","unstructured":"Zeng, F. et al. Effect of CD38 on B-cell function and its role in the diagnosis and treatment of B-cell-related diseases. J. Cell. Physiol. 237, 2796\u20132807 (2022).","journal-title":"J. Cell. Physiol."},{"key":"33151_CR27","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s11357-012-9488-5","volume":"35","author":"S Buffa","year":"2013","unstructured":"Buffa, S. et al. A novel B cell population revealed by a CD38\/CD24 gating strategy: CD38(-)CD24 (-) B cells in centenarian offspring and elderly people. Age (Dordr). 35, 2009\u20132024 (2013).","journal-title":"Age (Dordr)"},{"key":"33151_CR28","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.4049\/jimmunol.174.5.2687","volume":"174","author":"ME Moreno-Garc\u00eda","year":"2005","unstructured":"Moreno-Garc\u00eda, M. E. et al. CD38 signaling regulates B lymphocyte activation via a phospholipase C (PLC)-gamma 2-independent, protein kinase C, phosphatidylcholine-PLC, and phospholipase D-dependent signaling cascade. J. Immunol. 174, 2687\u20132695 (2005).","journal-title":"J. Immunol."},{"key":"33151_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12672-022-00602-1","volume":"13","author":"Brum da Silva","year":"2022","unstructured":"Brum da Silva et al. Lymphocytes from B-acute lymphoblastic leukemia patients present differential regulation of the adenosinergic axis depending on risk stratification. Discov Oncol. 13, 143 (2022).","journal-title":"Discov Oncol."},{"key":"33151_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cellimm.2017.05.008","volume":"321","author":"JL Karnell","year":"2017","unstructured":"Karnell, J. L. et al. Role of CD11c\u2009+\u2009T-bet\u2009+\u2009B cells in human health and disease. Cell. Immunol. 321, 40\u201345 (2017).","journal-title":"Cell. Immunol."},{"key":"33151_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cellimm.2017.07.006","volume":"321","author":"GM Winslow","year":"2017","unstructured":"Winslow, G. M., Papillion, A. M., Kenderes, K. J. & Levack, R. C. CD11c\u2009+\u2009T-bet\u2009+\u2009memory B cells: immune maintenance during chronic infection and inflammation? Cell. Immunol. 321, 8\u201317 (2017).","journal-title":"Cell. Immunol."},{"key":"33151_CR32","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1038\/sj.onc.1210922","volume":"27","author":"JH Zhu","year":"2008","unstructured":"Zhu, J. H. et al. Protein tyrosine phosphatase PTPN13 negatively regulates Her2\/ErbB2 malignant signaling. Oncogene 27, 2525\u20132531 (2008).","journal-title":"Oncogene"},{"key":"33151_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.str.2007.12.021","volume":"16","author":"Y Xing","year":"2008","unstructured":"Xing, Y. et al. Crystal structure of a full-length beta-catenin. Structure 16, 478\u2013487 (2008).","journal-title":"Structure"},{"key":"33151_CR34","doi-asserted-by":"publisher","first-page":"BSR20191692","DOI":"10.1042\/BSR20191692","volume":"39","author":"BJ DuChez","year":"2019","unstructured":"DuChez, B. J. et al. Characterization of the interaction between \u03b2-catenin and sorting nexin 27: contribution of the type I PDZ-binding motif to Wnt signaling. Biosci. Rep. 39, BSR20191692 (2019).","journal-title":"Biosci. Rep."},{"key":"33151_CR35","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2174\/092986606778256126","volume":"13","author":"A Ress","year":"2006","unstructured":"Ress, A. & Moelling, K. Interaction partners of the PDZ domain of erbin. Protein Pept. Lett. 13, 877\u2013881 (2006).","journal-title":"Protein Pept. Lett."},{"key":"33151_CR36","doi-asserted-by":"publisher","first-page":"35851","DOI":"10.18632\/oncotarget.5323","volume":"6","author":"Q Ma","year":"2015","unstructured":"Ma, Q. et al. MAGI3 negatively regulates Wnt\/\u03b2-catenin signaling and suppresses malignant phenotypes of glioma cells. Oncotarget 6, 35851\u201335865 (2015).","journal-title":"Oncotarget"},{"key":"33151_CR37","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1016\/j.bbamcr.2016.06.010","volume":"1863","author":"MS Dar","year":"2016","unstructured":"Dar, M. S. et al. Terminal regions of \u03b2-catenin are critical for regulating its adhesion and transcription functions. Biochim. Biophys. Acta. 1863, 2345\u20132357 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"33151_CR38","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1128\/MCB.01986-07","volume":"28","author":"C Sustmann","year":"2008","unstructured":"Sustmann, C., Flach, H., Ebert, H., Eastman, Q. & Grosschedl, R. Cell-type-specific function of BCL9 involves a transcriptional activation domain that synergizes with beta-catenin. Mol. Cell. Biol. 28, 3526\u20133537 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"33151_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jmb.2008.09.034","volume":"384","author":"J Zhang","year":"2008","unstructured":"Zhang, J. et al. Structural basis of beta-catenin recognition by Tax-interacting protein-1. J. Mol. Biol. 384, 255\u2013263 (2008).","journal-title":"J. Mol. Biol."},{"key":"33151_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1600-065X.2009.00801.x","volume":"230","author":"L Nitschke","year":"2009","unstructured":"Nitschke, L. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions. Immunol. Rev. 230, 128\u2013143 (2009).","journal-title":"Immunol. Rev."},{"key":"33151_CR41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1006\/smim.1998.0125","volume":"10","author":"KA Siminovitch","year":"1998","unstructured":"Siminovitch, K. A. & Neel, B. G. Regulation of B cell signal transduction by SH2-containing protein-tyrosine phosphatases. Semin Immunol. 10, 329\u2013347 (1998).","journal-title":"Semin Immunol."},{"key":"33151_CR42","doi-asserted-by":"publisher","first-page":"11814","DOI":"10.1073\/pnas.92.25.11814","volume":"92","author":"Y Kikuchi","year":"1995","unstructured":"Kikuchi, Y., Yasue, T., Miyake, K., Kimoto, M. & Takatsu, K. CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of Interleukin 5-receptor alpha chain: synergistic effects with Interleukin 5. Proc. Natl. Acad. Sci. U S A. 92, 11814\u201311818 (1995).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"33151_CR43","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1182\/blood-2007-08-107714","volume":"111","author":"JC Rodr\u00edguez-Alba","year":"2008","unstructured":"Rodr\u00edguez-Alba, J. C., Moreno-Garc\u00eda, M. E., Sandoval-Montes, C. & Rosales-Garcia, V. H. Santos-Argumedo, L. CD38 induces differentiation of immature transitional 2 B lymphocytes in the spleen. Blood 111, 3644\u20133652 (2008).","journal-title":"Blood"},{"key":"33151_CR44","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/ijms21031098","volume":"21","author":"F Chiarini","year":"2020","unstructured":"Chiarini, F., Paganelli, F., Martelli, A. M. & Evangelisti, C. The role played by Wnt\/\u03b2-catenin signaling pathway in acute lymphoblastic leukemia. Int. J. Mol. Sci. 21, 1098 (2020).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33151-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33151-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33151-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:06:36Z","timestamp":1769220396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33151-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33151"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33151-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Studies conducted with patient samples were performed according to institutional guidelines, and approved by the Research Ethics Board at the Hospital for Sick Children (research study 0020010197), and by the Boston Children\u2019s Hospital Committee on Clinical Investigation (research study 04-09-113R).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval"}},{"value":"Informed consent was obtained from the parents of the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All contributing authors approved the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"3173"}}